why choose us

First received: December 16, 2022

Clinical Trial: Study of a Cohort of Children With Molluscum Contagiosum (MC) Treated With a 5% Solution of Potassium Hydroxide (Molutrex®) Applied Locally to the Skin

Study Status: Completed

Recruit Status: RECRUITING

Condition: Molluscum Contagiosum

Study Type: OBSERVATIONAL


Official Title: Multicenter National Observational and Prospective Study of a Cohort of Children With Molluscum Contagiosum (MC) Treated With a 5% Solution of Potassium Hydroxide (Molutrex®) Applied Locally to the Sk

Brief Summary: Molutrex® a 5% potassium hydroxide solution for topical application to the skin.Molutrex® is intended for the superficial treatment of certain types of warts, molluscum contagiosum and is composed of potassium hydroxide (5%) purified water.With regard to the 2017/745 RDM, he is a class IIa medical device.In accordance with Regulation (EU) 2017/745 of the European Parliament and of the Council of April 5, 2017 relating to medical devices, as part of the Molutrex® Post-Marketing Monitoring Plan, the…

Read more